21 Jul 2017
Presented by: Robert Jeng, Senior Scientific Analyst, Will Akie, Product Manager for Pharmapremia, and Ellen Moore of Pharma Consulting.
Pharmapremia gives you the ability to accurately benchmark internal and external R&D candidates’ chances of approval and potential development timelines. You can use these benchmarks to make informed decisions about drug pipeline prioritization, partnerships and acquisitions.
How it can help
Pharmapremia allows you to look at product success factors across the variables that matter to you and your business. Its robust dataset includes detailed information from the entire drug-development industry, from big pharma to private biotech, oncology to orphan diseases.
This data gives you an exclusive window into drug development pipelines and paints a fuller, clearer picture of how the industry is performing.
How it works
Effectively manage your portfolio risk by accessing comprehensive data sets including Probability of Overall Success (POS), Likelihood of Approval (LOA) and Phase and Overall Duration.
Pharmapremia covers over 8,000 programs including over 2,200 in oncology, over 1,100 in orphan diseases, and over 500 indications.
Comprehensive data sets allow you to spot and hedge against dangers
Examine components critical to clinical and regulatory success
Construct crucial points of reference to help measure your success
Our proven success rate methodology has been published in, Nature Biotechnology
29 Jun 2017
Drill deeper into industry-standard data using peer-reviewed methodology to gain insights you can bank on. Pharmapremia can bring confidence to the accuracy of your benchmarks.
Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.
Request live demo now:
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: